Please provide your email address to receive an email when new articles are posted on . Among patients with focal segmental glomerulosclerosis, immunosuppressant therapy reduced proteinuria but showed ...

Please provide your email address to receive an email when new articles are posted on . Eltrombopag increased response rates when added to standard immunosuppressive therapy among patients with ...

Purpose: Factors associated with adherence to immunosuppressant therapy (IST) in renal transplant recipients were studied. Methods: The Immunosuppressant Therapy Adherence Scale (ITAS) was completed ...

Lupus nephritis treatment duration and regimens reflect dynamic patient needs. Nearly half of patients with newly diagnosed lupus nephritis (LN) in a US cohort began treatment with an ...

A minority of patients will experience flares, but in most cases reintroduction of therapy will result in remission. Patients taking glucocorticoids and other immunosuppressants for systemic lupus ...

When introduced with a new immunosuppressant treatment, people with systemic lupus erythematosus (SLE) typically see clinical improvement of extrarenal flares within 6 months. A new study published in ...

Patients who received early immunosuppressive therapy for their rheumatoid arthritis (RA)–associated peripheral ulcerative keratitis experienced earlier inflammatory control, fewer recurrences, and ...

Medeor Therapeutics’ kidney transplant cell therapy, which combines a living donor’s cells with the recipient's, allowed more than half of study participants in a phase 3 pivotal trial to stay off ...

In a recent study posted to the medRxiv* preprint server, researchers evaluated the impact of immunosuppressive therapies on the induction of adaptive immunity after coronavirus disease 2019 (COVID-19 ...

Vertex is providing an initial peek at the first patient to receive a new type of diabetes cell therapy that could prevent the need for a cell transplant. A single patient with type 1 diabetes ...